Equities

Genus PLC

GNS:LSE

Genus PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)1,736.00
  • Today's Change32.00 / 1.88%
  • Shares traded40.00k
  • 1 Year change-36.04%
  • Beta0.2551
Data delayed at least 20 minutes, as of Apr 26 2024 18:08 BST.
More ▼

Profile data is unavailable for this security.

About the company

Genus plc is a United Kingdom-based animal protein genetics company. The Company supplies breeding animals with desirable characteristics for farmers, enabling them to produce quality meat and milk. Its segments include Genus PIC, Genus ABS and Genus Research and Development. The Genus PIC segment is engaged in the porcine sales business. The Genus ABS segment is engaged in the bovine sales business. Its bovine genetics business sells dairy and beef bull semen and embryos from its superior cattle, which are sold to farmers to breed their cows through artificial insemination. Its porcine genetics business sells genetically superior breeding pigs and semen to farmers, so they can breed commercial pigs with desirable characteristics for pork production. It also provides technical services and advice to farmers, to maximize the performance of its breeding animals in their farms. The Company has supply chain and distribution networks in over 80 countries.

  • Revenue in GBP (TTM)673.10m
  • Net income in GBP33.40m
  • Incorporated1994
  • Employees3.48k
  • Location
    Genus PLCMatrix House, Basing ViewBASINGSTOKE RG21 4DZUnited KingdomGBR
  • Phone+44 12 5634 7100Fax+44 12 5647 7385
  • Websitehttps://www.genusplc.com
More ▼

Peer analysis

CompanyRevenue (TTM)Net income (TTM)Market capEmployeesMarket Cap /
Employees
Bioventix PLC13.60m8.67m232.27m16.00232.27m16.00
Niox Group PLC36.80m9.50m281.55m85.00281.55m85.00
Puretech Health PLC9.40m-37.64m589.62m111.00589.62m111.00
Genus plc673.10m33.40m1.15bn3.48k1.15bn3.48k
Worldwide Healthcare Trust PLC-66.33m-95.44m1.83bn0.001.83bn0.00
Indivior PLC899.99m4.00m1.91bn1.05k1.91bn1.05k
Hikma Pharmaceuticals Plc2.30bn152.13m4.25bn8.97k4.25bn8.97k
Data as of Apr 26 2024. Currency figures normalised to Genus PLC's reporting currency: UK Pound GBX

Institutional shareholders

47.89%Per cent of shares held by top holders
HolderShares% Held
Baillie Gifford & Co.as of 01 Sep 20235.68m8.61%
Wellington Management Co. LLPas of 01 Sep 20233.93m5.96%
Vanguard Advisers, Inc.as of 01 Mar 20243.65m5.53%
Capital Research & Management Co. (World Investors)as of 01 Sep 20233.29m4.98%
abrdn Investments Ltd.as of 01 Sep 20232.98m4.52%
Threadneedle Asset Management Ltd.as of 01 Sep 20232.82m4.28%
Devon Equity Management Ltd.as of 01 Sep 20232.79m4.22%
BlackRock Fund Advisorsas of 01 Sep 20232.59m3.92%
The Vanguard Group, Inc.as of 01 Sep 20232.31m3.50%
Norges Bank Investment Managementas of 01 Mar 20241.58m2.39%
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.